Another study (Sawalha, 2019) suggests that BCL-6 and EZH2 cooperate to inhibit miR-142-3p/5p expression in SLE CD4+T cells through epigenetic modification. The gene discussed is BCL6; the disease is systemic lupus erythematosus.